OTEX Q1 2026 Earnings EPS Beats Estimates by 746 Shares Edge Higher CZFS Q1 2026 Earnings EPS Beat of 695 Lifts Shares as Revenue Details Remain Undisclosed Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development DFTX Q1 2026 Earnings Missed EPS Estimates as Pipeline Costs Weigh on Results USAC Q1 2026 Earnings EPS Miss Sends Units Lower as Operational Costs Weigh BWFG Q1 2026 Earnings EPS Beats Estimates by 13 Amid Solid Operating Performance